People: Sienna Biopharmaceuticals Inc (SNNA.OQ)
23 Aug 2019
Mr. James M. Hindman is Director of the Company. Mr. Hindman, served at Allergan, Inc., a multi-specialty healthcare company, from 1984 to March 2015, where he held positions of increasing responsibility, and most recently served as its Executive Vice President and Chief Financial Officer. From 2002 to August 2014, he served as Senior Vice President of Treasury, Risk and Investor Relations, and, from 1984 to 2002, served a variety of other finance positions at Allergan Inc., including Senior Vice President, Finance and Controller, Vice President, Finance, Vice President, Financial Planning and Analysis, and Assistant Corporate Controller. Mr. Hindman has served on the board of Millendo Therapeutics, Inc., a private biotechnology company, since June 2016. He has also provided financial consulting services to Cidara Therapeutics Inc., a public biotechnology company, since July 2015, and to RANI Therapeutics, a privately held biotechnology company, since December 2017. Mr. Hindman has served as a member of the Board of Regents at Loyola Marymount University since June 2015 and served on their Accounting Advisory Board from 2007 to June 2015. Mr. Hindman served as a member of the board of directors of The Allergan Foundation, a private charitable foundation, from 2009 to December 2015. He received a B.S. in Accounting from Loyola Marymount University, an M.B.A. from Pepperdine University, and is a Certified Public Accountant (inactive). Mr. Hindman was selected as a director because of his significant financial experience in the life sciences industry.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|